752 related articles for article (PubMed ID: 10569477)
21. Osteoclast stimulating and differentiating factors in human cholesteatoma.
Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
[TBL] [Abstract][Full Text] [Related]
22. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
Ishida M; Amano S
J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts.
Miyamoto A; Kunisada T; Hemmi H; Yamane T; Yasuda H; Miyake K; Yamazaki H; Hayashi SI
Biochem Biophys Res Commun; 1998 Jan; 242(3):703-9. PubMed ID: 9464281
[TBL] [Abstract][Full Text] [Related]
24. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
Lees RL; Heersche JN
J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
[TBL] [Abstract][Full Text] [Related]
25. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
27. Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production.
Tsuboi H; Udagawa N; Hashimoto J; Yoshikawa H; Takahashi N; Ochi T
Arthritis Rheum; 2005 Dec; 52(12):3819-28. PubMed ID: 16320327
[TBL] [Abstract][Full Text] [Related]
28. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
30. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
Islam S; Hassan F; Tumurkhuu G; Dagvadorj J; Koide N; Naiki Y; Mori I; Yoshida T; Yokochi T
Biochem Biophys Res Commun; 2007 Aug; 360(2):346-51. PubMed ID: 17597583
[TBL] [Abstract][Full Text] [Related]
31. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020
[TBL] [Abstract][Full Text] [Related]
32. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
34. Treg cells suppress osteoclast formation: a new link between the immune system and bone.
Zaiss MM; Axmann R; Zwerina J; Polzer K; Gückel E; Skapenko A; Schulze-Koops H; Horwood N; Cope A; Schett G
Arthritis Rheum; 2007 Dec; 56(12):4104-12. PubMed ID: 18050211
[TBL] [Abstract][Full Text] [Related]
35. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
36. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
[TBL] [Abstract][Full Text] [Related]
37. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
38. Macrophage-osteoclast differentiation and bone resorption in osteoarthrotic subchondral acetabular cysts.
Sabokbar A; Crawford R; Murray DW; Athanasou NA
Acta Orthop Scand; 2000 Jun; 71(3):255-61. PubMed ID: 10919296
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients.
Takano H; Tomita T; Toyosaki-Maeda T; Maeda-Tanimura M; Tsuboi H; Takeuchi E; Kaneko M; Shi K; Takahi K; Myoui A; Yoshikawa H; Takahashi T; Suzuki R; Ochi T
Rheumatology (Oxford); 2004 Apr; 43(4):435-41. PubMed ID: 14762224
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
